Octave Strengthens Clinical Expertise in MS and Neurodegenerative Disease – Read the Release

Recent Announcements & Press

Octave CEO Doug Biehn on NYSE Floor Talk with Judy Shaw

High Notes: Octave Biosciences’ Protein Panel Predicts MS Trajectory- Inside Precision Medicine

Octave® Bioscience, Inc. Announces Publication in Nature Communications- Businesswire

Octave Note

Leveraging Biology for Better Informed Treatment Decisions

Precision Medicine: Biomarkers as an Objective Measure

Octave at ECTRIMS: An Overview of Scientific Research Presented on Our MS Precision Care Solution

Media Library

living well

Being Diagnosed with Multiple Sclerosis

living well

Earliest Stages of Multiple Sclerosis

living well

Is My MS Controlled?